Table 2.
Parameter | Mean | SD |
---|---|---|
Patient age at diagnosis (years) | 35.4 | 15.8 |
Time to recurrence (months) | 16.4 | 12.3 |
Followup (months) | 108.3 | 43.8 |
Number | Percent | |
---|---|---|
Gender | ||
Male | 53 | 45.3 |
Female | 65 | 54.7 |
Location | ||
Distal femur | 29 | 24.6 |
Proximal femur | 4 | 3.4 |
Distal tibia | 6 | 5.1 |
Proximal tibia | 24 | 20.3 |
Proximal fibula | 3 | 2.5 |
Distal humerus | 1 | 0.8 |
Proximal humerus | 4 | 3.4 |
Distal radius | 12 | 10.2 |
Distal ulna | 2 | 1.7 |
Proximal ulna | 1 | 0.8 |
Hand | 4 | 3.4 |
Scapula | 1 | 0.8 |
Spine | 6 | 5.1 |
Sacrum | 13 | 11.0 |
Pelvis | 9 | 7.6 |
Grade (Campanacci) | ||
Grade I | 5 | 4.2 |
Grade II | 46 | 39.0 |
Grade III | 67 | 56.8 |
Tumor extension | ||
T1 | 62 | 52.5 |
T2 | 56 | 47.5 |
Pathologic fracture | 17 | 14.4 |
Treatment | ||
Wide resection | 22 | 18.6 |
Intralesional surgery | 95 | 80.5 |
Nonsurgical treatment | 1 | 0.9 |
Adjuvants | ||
No adjuvants (bone grafting) | 22 | 23.2 |
Bone grafting + phenol | 32 | 33.7 |
PMMA | 1 | 1.1 |
PMMA + phenol | 40 | 42.2 |
Recurrences–total | 25 | 21.4 |
Recurrences–bone | 21 | 17.9 |
Soft tissue implantations | 4 | 3.4 |